Bradley Schlaggar, M.D., Ph.D.
President and CEO
Kennedy Krieger Institute
Pediatric neurologist and developmental cognitive neuroscientist Dr. Bradley Schlaggar has emerged as a champion for the principles of equity, diversity and inclusion for people living with disorders of the developing nervous system.
Since he arrived at Kennedy Krieger just over four years ago, he has brought a clear message that the values and objectives they embrace for the people they serve are the same values that must be embraced within the organization.
In 2020, the institute created an Office of Health, Equity, Inclusion and Diversity. Kennedy Krieger is also building a highly innovative Center for the Neuroscience of Social Injustice to address the role of adverse childhood experiences on a child’s development.
“I feel extraordinarily fortunate to serve as CEO of Kennedy Krieger Institute, working side by side with the most remarkable, mission-driven colleagues I’ve ever encountered,” Schlaggar said.
He is a professor in the Department of Neurology and Pediatrics at the Johns Hopkins School of Medicine.
Over the past two years, the institute has completely reimagined the institute’s clinical trials unit, and recruited one of the foremost experts in such trials to grow the infrastructure for clinical trial investigation and innovate treatment options for children.
“Kennedy Krieger is truly unique — there is no place like us anywhere in the U.S. or beyond,” Schlaggar said. “We celebrate our opportunity to help shine a bright and positive light on our home.”
He earned his MD and his doctorate in neuroscience from Washington University School of Medicine and his Bachelor of Science in neural science at Brown University.
He previously served as director of Pediatric and Developmental Neurology at Washington University School of Medicine and the neurologist-in-chief at the St. Louis Children’s Hospital.